GWC and GS conceived and drafted the first version of this Editorial. All the authors contributed to draft and critically revised the manuscript. All the authors read and approved the final manuscript.
FB is the current President of the Italian Respiratory Society (SIP/IRS). GWC is the current President of the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) and President of INTERASMA-Global Asthma Association. MC is the current Junior Members Chairpersons of the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and member of GINA Italy initiative. EH is the current Secretary General of the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC). ML is a member of GINA Italy Initiative. PLP is the current Chairman of GINA Italy, and Member of the GINA International Executive Committee. GS is the current vice-President of the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and member of GINA Italy initiative. All the Authors are members of the SANI Scientific Board.
The authors would like to thank the following members of SANI-Severe Asthma Network in Italy: Adiletta Girolamo (Savona), Bonavia Marco (Genova), Bucca Caterina (Torino), Caiaffa Maria Filomena (Foggia), Calabrese Cecilia (Napoli), Camiciottoli Gianna (Firenze), Capano Pasquale (Salerno), Centanni Stefano (Milano), Chieco Bianchi Fulvia (Padova), Colombo Giselda (Milano), Corsico Angelo Guido (Pavia), Costantino Maria Teresa (Mantova), Crimi Nunzio (Catania), Crivellaro Mariangiola (Padova), D’Amato Maria (Napoli), Del Giacco Stefano (Cagliari), De Paulis Amato (Napoli), Di Gioacchino Mario (Chieti), Di Maria Giuseppe (Catania), Domenico Schiavino (Roma), Favero Elisabetta (Treviso), Foschino Maria Pia (Foggia), Girbino Giuseppe (Messina), Guarnieri Gabriella (Padova), Lombardi Carlo (Brescia), Macchia Luigi (Bari), Maestrelli Piero (Padova), Maggi Enrico (Firenze), Marinari Stefano (Chieti), Maselli Rosario (Catanzaro), Milanese Manlio (Savona), Nava Stefano (Bologna), Papi Alberto (Ferrara), Patella Vincenzo (Salerno), Pelaia Girolamo (Catanzaro), Poto Sergio (Salerno), Ridolo Erminia (Parma), Rolla Giovanni (Torino), Rottoli Paola (Siena), Santus Pierachille (Milano), Savi Eleonora (Piacenza), Schiavino Domenico (Roma), Schichilone Nicola (Palermo), Severino Maurizio Giuseppe (Firenze), Spadaro Giuseppe (Napoli), Stanziola Anna (Napoli), Torchio Roberto (Torino), Triggiani Massimo (Napoli), Vianello Andrea (Padova), Zappa Maria Cristina (Roma).
The authors also acknowledge the following companies supporting SANI Project: AstraZeneca, GSK, Novartis, Sanofi and Teva.
A special thank to Ettore Benedetti for technical and bioinformatics support to the SANI project.
A special thank to Teresa Colombo for her assistance in the SANI project.
FB has received in the last 3 years speaker or consultant honoraria or research funding from: Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Lab. Guidotti e Malesci, Menarini, Mundipharma, Novartis, Pfizer,Teva,Valeas and Zambon. MC has received grants for educational programs from Novartis and Menarini. GWC has served as panelist in Advisory Boards and/or speaker in meetings and was member of trials for GSK, Novartis, AZ, Teva, Sanofi. ML has received grants for research and educational programs from AZ and Mundipharma.
MG in the last 2 years has served as bio-statistical consultant for GSK, AZ, TEVA, Novartis. EH has no competing interests to declare. PP received personal and institutional grant for education and research from: AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Guidotti, Menarini, Mundipharma, Novartis, Roche, Sanofi, Teva. GS has served as panelist in Advisory Boards for Novartis and GSK.
Availability of data and materials
Requests can be sent to the corresponding author.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.